caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1518080639

Rebecca EisenbergM.D.

Medical OncologySanford, MEI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Rebecca Eisenberg's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 31 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
LEE, PETER86253
David Kwon
Diagnostic Radiology · Greensboro, NC
71180
NPI 120588399859113
Meghan Jewett
Nurse Practitioner · Stoneham, MA
54179
Joshua Stein
Diagnostic Radiology · Melrose, MA
53134
THE GENERAL HOSPITAL CORPORATION32132
Olga Efimova
Diagnostic Radiology · Melrose, MA
3270
BHIDE, GAURI31106
Laurence Conway
Cardiology · Medford, MA
2689
Carolyn Fallica
Nurse Practitioner · Stoneham, MA
2373
RIFFELMACHER, GERALD2287
Armstrong Ambulance Service
Ambulance Service Provider · Arlington, MA
2055
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
245
Unique beneficiaries
—
Total services
460
Distinct HCPCS
4
Medicare payment
$34K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 15 Medical Oncology providers in ME — above median (cohort median 395).
PRESCRIBING · PART D · 2024
Total Rx claims
516
Beneficiaries
—
Total drug cost
$771K
Distinct drugs
17
Brand share
18.4%
Top prescribed drugs
Prochlorperazine Maleate78 claims
Anastrozole65 claims
Dexamethasone56 claims
Ondansetron Hcl53 claims
Oxycodone Hcl41 claims
QUALITY · MIPS · 2024
Final MIPS score
97.9
Quality
83.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.97%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.